Skip to main content

Table 1 Relative risk for tobacco smoking and cancer in Korea

From: Attributable fraction of tobacco smoking on cancer using population-based nationwide cancer incidence and mortality data in Korea

Cancer site (ICD-10)

Gender

Pooled RR (95% CI)

Sources of pooled RR (OR)

Incidence

Mortality

Former smokers

Current smokers

Former smokers

Current smokers

Oral Cavity (C00-C09)a

Men

1.03 (0.63-1.68)

2.19 (1.54-3.12)

0.80 (0.10-13.50)

3.30 (0.50-34.60)

[20, 21]

 

Women

-

6.70 (1.10-39.40)b

0.80 (0.10-13.50)c

3.30 (0.50-34.60)c

[21]

Pharynx (C10-C14)a

Men

1.03 (0.63-1.68)

2.19 (1.54-3.12)

0.80 (0.10-13.50)

3.30 (0.50-34.60)

[20, 21]

 

Women

-

6.70 (1.10-39.40)b

0.80 (0.10-13.50)c

3.30 (0.50-34.60)c

[21]

Esophagus (C15)

Men

1.20 (1.05-1.37)

2.23 (1.99-2.50)

1.45 (1.21-1.73)

2.64 (2.25-3.09)

[20, 21, 26]

 

Women

1.10 (0.40-3.10)

1.60 (0.80-3.10)

1.60 (0.60-5.10)

0.90 (0.30-2.70)

[21]

Stomach (C16)

Men

1.22 (0.87-1.71)

1.51 (1.46-1.55)

1.31 (1.21-1.41)

1.60 (1.51-1.71)

[20, 21, 23, 27, 28, 34]

 

Women

1.22 (0.87-1.71)c

1.51 (1.46-1.55)c

1.01 (0.83-1.24)

1.04 (0.85-1.26)

[21, 27]

Colorectum (C18-C20)

Men

1.13 (1.02-1.26)

0.98 (0.78-1.23)

1.10 (0.90-1.40)

1.10 (0.80-1.40)

[20, 21, 24, 33]

 

Women

1.07 (0.70-1.63)

0.97 (0.76-1.25)

1.10 (0.90-1.40)c

1.10 (0.80-1.40)c

[24, 33]

Liver (C22)

Men

1.20 (1.10-1.30)

1.40 (1.30-1.50)

1.20 (1.00-1.30)

1.40 (1.30-1.60)

[21]

 

Women

0.80 (0.10-5.60)

2.50 (1.00-6.30)

1.90 (0.30-14.20)

2.60 (0.60-11.00)

[21]

Pancreas (C25)

Men

1.20 (1.00-1.40)

1.50 (1.30-1.70)

1.11 (0.93-1.33)

1.50 (1.31-1.71)

[21, 27]

 

Women

0.80 (0.50-1.10)

1.20 (0.90-1.50)

0.90 (0.5-1.20)

1.10 (0.80-1.40)

[21]

Larynx (C32)

Men

2.01 (1.49-2.73)

4.65 (3.61-6.00)

1.70 (1.00-2.90)

4.50 (2.80-7.10)

[20, 21]

 

Women

0.90 (0.10-6.80)

9.10 (4.60-17.80)

0.90 (0.10-6.90)

3.60 (1.30-9.70)

[21]

Lung (C33-C34)

Men

1.21 (0.87-1.69)

2.58 (1.83-3.63)

1.82 (1.63-2.03)

4.40 (3.98-4.87)

[19–21, 25, 27, 30, 31, 36]

 

Women

1.65 (1.37-1.99)

2.37 (2.09-2.68)

1.90 (1.50-2.40)

3.20 (2.70-3.70)

[21, 31]

Cervix uteri (C53)

Women

1.15 (0.87-1.52)

1.12 (0.92-1.35)

1.20 (0.60-2.40)

1.80 (1.10-2.80)

[18, 20, 21, 35]

Ovary (C56)

Women

1.12 (0.90-1.39)

2.07 (1.65-2.60)

1.12 (0.90-1.39)d

2.07 (1.65-2.60)d

[22, 29]

Kidney (C64)

Men

1.10 (0.90-1.20)

1.10 (0.90-1.20)

1.00 (0.70-1.40)

1.10 (0.80-1.50)

[21]

 

Women

1.10 (0.60-2.10)

1.00 (0.60-1.60)

2.30 (0.90-6.30)

1.50 (0.60-3.90)

[21]

Bladder (C67)

Men

1.50 (1.30-1.70)

2.00 (1.70-2.30)

1.30 (0.90-1.90)

2.10 (1.40-2.90)

[21]

 

Women

0.92 (0.53-1.58)

1.73 (1.26-2.38)

0.70 (0.20-2.20)

2.00 (1.10-3.80)

[21, 32]

  1. aRR for cancers of the oral cavity and pharynx combined was used; bRR for ever-smoker (past + current smokers); cRR for men was used for women; dRR for incidence was used.